| UniProt ID | ERAP1_HUMAN | |
|---|---|---|
| UniProt AC | Q9NZ08 | |
| Protein Name | Endoplasmic reticulum aminopeptidase 1 | |
| Gene Name | ERAP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 941 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type II membrane protein . |
|
| Protein Description | Aminopeptidase that plays a central role in peptide trimming, a step required for the generation of most HLA class I-binding peptides. Peptide trimming is essential to customize longer precursor peptides to fit them to the correct length required for presentation on MHC class I molecules. Strongly prefers substrates 9-16 residues long. Rapidly degrades 13-mer to a 9-mer and then stops. Preferentially hydrolyzes the residue Leu and peptides with a hydrophobic C-terminus, while it has weak activity toward peptides with charged C-terminus. May play a role in the inactivation of peptide hormones. May be involved in the regulation of blood pressure through the inactivation of angiotensin II and/or the generation of bradykinin in the kidney.. | |
| Protein Sequence | MVFLPLKWSLATMSFLLSSLLALLTVSTPSWCQSTEASPKRSDGTPFPWNKIRLPEYVIPVHYDLLIHANLTTLTFWGTTKVEITASQPTSTIILHSHHLQISRATLRKGAGERLSEEPLQVLEHPRQEQIALLAPEPLLVGLPYTVVIHYAGNLSETFHGFYKSTYRTKEGELRILASTQFEPTAARMAFPCFDEPAFKASFSIKIRREPRHLAISNMPLVKSVTVAEGLIEDHFDVTVKMSTYLVAFIISDFESVSKITKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDAEKSSASSKLGITMTVAHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVSVTHPELKVGDYFFGKCFDAMEVDALNSSHPVSTPVENPAQIREMFDDVSYDKGACILNMLREYLSADAFKSGIVQYLQKHSYKNTKNEDLWDSMASICPTDGVKGMDGFCSRSQHSSSSSHWHQEGVDVKTMMNTWTLQKGFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGNLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEKLERM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | VFLPLKWSLATMSFL CCCCCCHHHHHHHHH | 13.41 | 21406692 | |
| 12 | Phosphorylation | PLKWSLATMSFLLSS CCCHHHHHHHHHHHH | 20.74 | 21406692 | |
| 12 (in isoform 2) | Phosphorylation | - | 20.74 | 21406692 | |
| 14 (in isoform 2) | Phosphorylation | - | 14.37 | 21406692 | |
| 14 | Phosphorylation | KWSLATMSFLLSSLL CHHHHHHHHHHHHHH | 14.37 | 21406692 | |
| 18 | Phosphorylation | ATMSFLLSSLLALLT HHHHHHHHHHHHHHH | 22.53 | 21406692 | |
| 19 | Phosphorylation | TMSFLLSSLLALLTV HHHHHHHHHHHHHHC | 27.63 | 21406692 | |
| 25 | Phosphorylation | SSLLALLTVSTPSWC HHHHHHHHCCCCHHH | 17.17 | 21406692 | |
| 27 | Phosphorylation | LLALLTVSTPSWCQS HHHHHHCCCCHHHHC | 29.39 | 21406692 | |
| 28 | Phosphorylation | LALLTVSTPSWCQST HHHHHCCCCHHHHCC | 19.60 | 21406692 | |
| 30 (in isoform 2) | Phosphorylation | - | 40.34 | 21406692 | |
| 30 | Phosphorylation | LLTVSTPSWCQSTEA HHHCCCCHHHHCCCC | 40.34 | 21406692 | |
| 34 | Phosphorylation | STPSWCQSTEASPKR CCCHHHHCCCCCCCC | 25.69 | 21406692 | |
| 35 | Phosphorylation | TPSWCQSTEASPKRS CCHHHHCCCCCCCCC | 15.08 | 21406692 | |
| 38 | Phosphorylation | WCQSTEASPKRSDGT HHHCCCCCCCCCCCC | 25.40 | 21406692 | |
| 70 | N-linked_Glycosylation | YDLLIHANLTTLTFW HHEEEECCCCEEEEE | 24.61 | 21478864 | |
| 154 | N-linked_Glycosylation | VVIHYAGNLSETFHG EEEEECCCHHHHCCE | 32.02 | 21478864 | |
| 179 (in isoform 2) | Phosphorylation | - | 21.21 | 21406692 | |
| 179 | Phosphorylation | GELRILASTQFEPTA CEEEEEEEECCCCCC | 21.21 | 20068231 | |
| 180 | Phosphorylation | ELRILASTQFEPTAA EEEEEEEECCCCCCH | 31.50 | 21406692 | |
| 185 (in isoform 2) | Phosphorylation | - | 26.25 | 21406692 | |
| 185 | Phosphorylation | ASTQFEPTAARMAFP EEECCCCCCHHHHCC | 26.25 | 20068231 | |
| 202 | Phosphorylation | DEPAFKASFSIKIRR CCCCCEEEEEEEECC | 21.81 | 24719451 | |
| 204 | Phosphorylation | PAFKASFSIKIRREP CCCEEEEEEEECCCC | 22.07 | 24719451 | |
| 268 (in isoform 2) | Phosphorylation | - | 12.05 | 27251275 | |
| 268 | Phosphorylation | TKSGVKVSVYAVPDK HCCCCEEEEEECCCC | 12.05 | 27251275 | |
| 270 | Phosphorylation | SGVKVSVYAVPDKIN CCCEEEEEECCCCCC | 8.38 | - | |
| 399 | Phosphorylation | PELKVGDYFFGKCFD CCCCCCCEECCCCCC | 8.55 | 20068231 | |
| 414 | N-linked_Glycosylation | AMEVDALNSSHPVST EEEHHHCCCCCCCCC | 43.09 | 19159218 | |
| 432 | Sulfoxidation | NPAQIREMFDDVSYD CHHHHHHHHHCCCCC | 2.99 | 30846556 | |
| 440 (in isoform 2) | Ubiquitination | - | 39.93 | - | |
| 440 | Ubiquitination | FDDVSYDKGACILNM HHCCCCCHHHHHHHH | 39.93 | - | |
| 451 | Phosphorylation | ILNMLREYLSADAFK HHHHHHHHHCHHHHH | 10.26 | - | |
| 458 | Ubiquitination | YLSADAFKSGIVQYL HHCHHHHHHHHHHHH | 49.87 | - | |
| 458 (in isoform 2) | Ubiquitination | - | 49.87 | - | |
| 464 | Phosphorylation | FKSGIVQYLQKHSYK HHHHHHHHHHHCCCC | 10.54 | - | |
| 473 | Phosphorylation | QKHSYKNTKNEDLWD HHCCCCCCCCHHHHH | 30.97 | 20068231 | |
| 481 | Phosphorylation | KNEDLWDSMASICPT CCHHHHHHHHHHCCC | 12.50 | 20068231 | |
| 484 | Phosphorylation | DLWDSMASICPTDGV HHHHHHHHHCCCCCC | 18.97 | 20068231 | |
| 488 | Phosphorylation | SMASICPTDGVKGMD HHHHHCCCCCCCCCC | 40.76 | 20068231 | |
| 499 | Phosphorylation | KGMDGFCSRSQHSSS CCCCCCCCCCCCCCC | 32.48 | 20068231 | |
| 505 | O-linked_Glycosylation | CSRSQHSSSSSHWHQ CCCCCCCCCCCCHHH | 31.92 | OGP | |
| 507 | O-linked_Glycosylation | RSQHSSSSSHWHQEG CCCCCCCCCCHHHCC | 28.33 | OGP | |
| 508 | O-linked_Glycosylation | SQHSSSSSHWHQEGV CCCCCCCCCHHHCCC | 32.32 | OGP | |
| 550 | Sulfoxidation | HMKQEHYMKGSDGAP CCCHHHCCCCCCCCC | 4.23 | 30846556 | |
| 559 | Phosphorylation | GSDGAPDTGYLWHVP CCCCCCCCCCEEEEE | 27.02 | - | |
| 608 | Phosphorylation | NVGMNGYYIVHYEDD ECCCCCEEEEEEECC | 9.62 | 17384208 | |
| 692 | Sulfoxidation | KLMEKRDMNEVETQF HHHHHCCHHHHHHHH | 5.52 | 21406390 | |
| 760 | N-linked_Glycosylation | KWKESNGNLSLPVDV HHHHHCCCCCCCCEE | 30.61 | 21478864 | |
| 811 | Acetylation | ALCRTQNKEKLQWLL EEECCCCHHHHHHHH | 46.54 | 7710561 | |
| 868 | Phosphorylation | VQKFELGSSSIAHMV HHHHCCCCCHHHHHH | 33.27 | 23663014 | |
| 869 | Phosphorylation | QKFELGSSSIAHMVM HHHCCCCCHHHHHHH | 24.78 | 23663014 | |
| 870 | Phosphorylation | KFELGSSSIAHMVMG HHCCCCCHHHHHHHC | 26.03 | 23663014 | |
| 879 | Phosphorylation | AHMVMGTTNQFSTRT HHHHHCCCCCCCCHH | 22.69 | 23532336 | |
| 883 | Phosphorylation | MGTTNQFSTRTRLEE HCCCCCCCCHHHHHH | 13.76 | 23532336 | |
| 901 | N-linked_Glycosylation | FFSSLKENGSQLRCV HHHHHHHCCHHHHHH | 54.55 | UniProtKB CARBOHYD |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ERAP1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERAP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERAP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MUL1_HUMAN | MUL1 | physical | 28514442 | |
| TM87A_HUMAN | TMEM87A | physical | 28514442 | |
| APOL2_HUMAN | APOL2 | physical | 28514442 | |
| MOT10_HUMAN | SLC16A10 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Structural basis for antigenic peptide precursor processing by theendoplasmic reticulum aminopeptidase ERAP1."; Nguyen T.T., Chang S.C., Evnouchidou I., York I.A., Zikos C.,Rock K.L., Goldberg A.L., Stratikos E., Stern L.J.; Nat. Struct. Mol. Biol. 18:604-613(2011). Cited for: X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 37-939 IN COMPLEX WITH ZINCIONS AND BESTATIN, FUNCTION, DISULFIDE BONDS, GLYCOSYLATION AT ASN-70;ASN-154 AND ASN-760, ACTIVE SITE, CATALYTIC ACTIVITY, SUBUNIT, ANDMUTAGENESIS OF TYR-438. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-414, AND MASSSPECTROMETRY. | |